IBD Live Q&A Recap and Stock Lists for Monday, Dec. 1, 2025

Investor's Business Daily 2 min read Intermediate
Investor’s Business Daily’s IBD Live session offers a concise Q&A recap and curated stock lists to help traders prepare for Monday, Dec. 1, 2025. This guide highlights frequently asked questions, useful reference links and the Ready List — a collection of stocks that satisfy IBD’s combined fundamental and technical screening. The Ready List is designed for traders who want names that already meet key metrics such as earnings acceleration, institutional sponsorship, relative strength and constructive chart patterns.

Beyond the Ready List, IBD Live compiles additional watchlists and sector-focused lineups to support various trading approaches. Each list includes tickers that passed automated scans and editorial review, along with notes on why a particular stock merits attention. For new members, the FAQs section quickly addresses how to interpret IBD’s proprietary screens, how to position size, and how to set stop-loss levels when a stock fails to hold critical support.

Useful links shared during the session point to screening tools, educational articles on technical setups, and the methodology behind IBD’s fundamental filters. The recap also outlines short-term market context and the sectors currently showing relative strength, so readers can prioritize stocks in leading groups.

How to use this recap: start with the Ready List to identify candidates, then overlay sector and market trend analysis. Use the watchlists for next-in-line stocks that could join the Ready List after a pattern breakout or earnings improvement. For traders focused on risk management, follow IBD’s guidance on trailing stops and scaling into positions rather than committing full size at the first signal.

This summary is intended to speed the learning curve for new and experienced traders alike, consolidating the IBD Live discussion into actionable lists and links. For full details and the complete set of tickers named during the session, refer to the original IBD Live post on Investor’s Business Daily.